-
UroLife study general questionnaire
Patients with non-muscle invasive bladder cancer (n=1512) completed paper-and-pencil or web-based questionnaires at 6 weeks (referring to pre-diagnosis lifestyle; n=1486) and 3... -
ReLife study quality of life questionnaire
The EORTC QLQ-C30 was completed at 3 (n=365), 12 (n=317) and 24 months (n=279) after surgery. -
PRIDE Study blood samples
First trimester blood samples (plasma, serum, whole blood) of ~1000 PRIDE Study participants, available for genetic and biochemical analyses. Stored at -80°C. -
UroLife study blood samples
EDTA and heparin plasma samples were collected at 3 (n=1280) and 15 months (n=1122) after diagnosis. Heparin plasma samples have been analysed for carotenoids at 3 and 15 months... -
ReLife study abdominal CT scans
Abdominal CT scans are availabe for n=349 patients. -
UroLife study molecular subtypes
Molecular subtype based on immunohistrochemistry performed on tissue microarrays is available for 389 T1 NMIBC tumours. -
PRIDE Study obstetric records
Selected clinical data from obstetric records covering the pregnancy period and puerperium. Necessitates additional consent, provided by ~70% of participants -
PRIDE Study paternal questionnaire data
Questionnaire data focusing on paternal exposures the 3 months before conception. Completed by the biological father, <50% participation rate. -
ReLife study body composition data
CT-based assessment of body composition is available for n=349 patients. -
PRISMA Questionnaire data
The extensive questionnaire covers a number of potential breast cancer risk predictors such as demographics, personal characteristics, reproductive characteristics, medication,... -
COVID-19 GWAS and Allele Frequency Lookup Dataset for GDI MS 8
This is the first part of the split 11 of the synthetic data dedicated for the GDI MS8 -
test
tasdasd -
Substudy UCC-SMART Oracle
SMART-ORACLE aims to determine the additional value of contrast-enhanced CT of the coronary and carotid arteries on top of traditional cardiovascular risk factors in patients... -
UCC-SMART
The UCC-SMART Study is a single-centre prospective cohort study, ongoing in both inclusion (600 new patients included per year) and follow-up, in which patient care and... -
Substudy UCC-SMART 2
Patients with a history of CVD or diabetes are invited to participate in the SMART-2 substudy. In this study, the baseline measurements of UCC-SMART are repeated in order to... -
COVID-19 GWAS and Allele Frequency Lookup Dataset with Population 12...
This dataset is being used as part of the GDI Milestone 8, containing VCFs and phenotypic data in CSV format about 41514 samples. The dataset consists only of synthetic data. -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data...